Matches in SemOpenAlex for { <https://semopenalex.org/work/W1225123808> ?p ?o ?g. }
- W1225123808 endingPage "653" @default.
- W1225123808 startingPage "644" @default.
- W1225123808 abstract "Progressive multiple sclerosis (MS) is a severely disabling neurological condition, and an effective treatment is urgently needed. Recently, high-dose biotin has emerged as a promising therapy for affected individuals. Initial clinical data have shown that daily doses of biotin of up to 300 mg can improve objective measures of MS-related disability. In this article, we review the biology of biotin and explore the properties of this ubiquitous coenzyme that may explain the encouraging responses seen in patients with progressive MS. The gradual worsening of neurological disability in patients with progressive MS is caused by progressive axonal loss or damage. The triggers for axonal loss in MS likely include both inflammatory demyelination of the myelin sheath and primary neurodegeneration caused by a state of virtual hypoxia within the neuron. Accordingly, targeting both these pathological processes could be effective in the treatment of progressive MS. Biotin is an essential co-factor for five carboxylases involved in fatty acid synthesis and energy production. We hypothesize that high-dose biotin is exerting a therapeutic effect in patients with progressive MS through two different and complementary mechanisms: by promoting axonal remyelination by enhancing myelin production and by reducing axonal hypoxia through enhanced energy production. This article is part of the Special Issue entitled 'Oligodendrocytes in Health and Disease'." @default.
- W1225123808 created "2016-06-24" @default.
- W1225123808 creator A5014816629 @default.
- W1225123808 creator A5019079377 @default.
- W1225123808 creator A5021292901 @default.
- W1225123808 creator A5072949155 @default.
- W1225123808 date "2016-11-01" @default.
- W1225123808 modified "2023-10-02" @default.
- W1225123808 title "Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis" @default.
- W1225123808 cites W1520184516 @default.
- W1225123808 cites W1883912487 @default.
- W1225123808 cites W1933220919 @default.
- W1225123808 cites W1964443714 @default.
- W1225123808 cites W1967314874 @default.
- W1225123808 cites W1968513811 @default.
- W1225123808 cites W1970217106 @default.
- W1225123808 cites W1970817420 @default.
- W1225123808 cites W1972752407 @default.
- W1225123808 cites W1972940302 @default.
- W1225123808 cites W1975497822 @default.
- W1225123808 cites W1975823659 @default.
- W1225123808 cites W1981616018 @default.
- W1225123808 cites W1982044564 @default.
- W1225123808 cites W1987904485 @default.
- W1225123808 cites W1988586000 @default.
- W1225123808 cites W1988722696 @default.
- W1225123808 cites W1989463587 @default.
- W1225123808 cites W1991726737 @default.
- W1225123808 cites W1993878784 @default.
- W1225123808 cites W1994990277 @default.
- W1225123808 cites W1998152325 @default.
- W1225123808 cites W2005419194 @default.
- W1225123808 cites W2006178657 @default.
- W1225123808 cites W2007983808 @default.
- W1225123808 cites W2009034058 @default.
- W1225123808 cites W2010418081 @default.
- W1225123808 cites W2013234597 @default.
- W1225123808 cites W2013775518 @default.
- W1225123808 cites W2014127183 @default.
- W1225123808 cites W2016044475 @default.
- W1225123808 cites W2016129775 @default.
- W1225123808 cites W2019232437 @default.
- W1225123808 cites W2019314253 @default.
- W1225123808 cites W2020672168 @default.
- W1225123808 cites W2021801532 @default.
- W1225123808 cites W2024751716 @default.
- W1225123808 cites W2025460536 @default.
- W1225123808 cites W2025732446 @default.
- W1225123808 cites W2026287451 @default.
- W1225123808 cites W2027285375 @default.
- W1225123808 cites W2028403598 @default.
- W1225123808 cites W2033060818 @default.
- W1225123808 cites W2033993719 @default.
- W1225123808 cites W2041891067 @default.
- W1225123808 cites W2042166711 @default.
- W1225123808 cites W2042961694 @default.
- W1225123808 cites W2044022462 @default.
- W1225123808 cites W2047045824 @default.
- W1225123808 cites W2047359131 @default.
- W1225123808 cites W2048082433 @default.
- W1225123808 cites W2050596253 @default.
- W1225123808 cites W2051570751 @default.
- W1225123808 cites W2054395536 @default.
- W1225123808 cites W2054914551 @default.
- W1225123808 cites W2058214824 @default.
- W1225123808 cites W2060975471 @default.
- W1225123808 cites W2061163762 @default.
- W1225123808 cites W2061447934 @default.
- W1225123808 cites W2063514287 @default.
- W1225123808 cites W2068357714 @default.
- W1225123808 cites W2070327017 @default.
- W1225123808 cites W2075483428 @default.
- W1225123808 cites W2076239574 @default.
- W1225123808 cites W2078482008 @default.
- W1225123808 cites W2085879860 @default.
- W1225123808 cites W2086766386 @default.
- W1225123808 cites W2086825927 @default.
- W1225123808 cites W2087042415 @default.
- W1225123808 cites W2087589796 @default.
- W1225123808 cites W2088347712 @default.
- W1225123808 cites W2089416663 @default.
- W1225123808 cites W2092982203 @default.
- W1225123808 cites W2096730504 @default.
- W1225123808 cites W2097114048 @default.
- W1225123808 cites W2098162819 @default.
- W1225123808 cites W2100830657 @default.
- W1225123808 cites W2101660242 @default.
- W1225123808 cites W2103529868 @default.
- W1225123808 cites W2103758700 @default.
- W1225123808 cites W2104930293 @default.
- W1225123808 cites W2104948944 @default.
- W1225123808 cites W2107345961 @default.
- W1225123808 cites W2107422246 @default.
- W1225123808 cites W2108979389 @default.
- W1225123808 cites W2111428020 @default.
- W1225123808 cites W2112285382 @default.
- W1225123808 cites W2112459516 @default.
- W1225123808 cites W2115818144 @default.